Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA

Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA

Abstract Introduction This post hoc analysis of VOLTAIRE-RA compared patient-reported outcomes, including health-related quality of life (HRQoL), in patients with rheumatoid arthritis (RA) before and after treatment with biosimilar adalimumab-adbm or adalimumab reference product. Methods HRQoL was a...

Full description

Bibliographic Details
Main Authors: Vibeke Strand, Shaun Bender, Dorothy McCabe
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-08-01
Series:Rheumatology and Therapy
Subjects:
Patient-reported outcomes
Rheumatoid arthritis
Adalimumab
Biosimilar
Online Access:https://doi.org/10.1007/s40744-024-00687-w

Internet

https://doi.org/10.1007/s40744-024-00687-w

Similar Items